|
Post by OLKoot on Apr 2, 2007 14:24:23 GMT 12.75
Merck wins FDA's OK for diabetes pill Sat Mar 31, 10:02 PM ET
WASHINGTON - A 2-in-1 medicine to treat diabetes has won federal approval, Merck & Co. Inc. said Saturday.
The tablet, called Janumet, combines a proprietary Merck drug with the older diabetes drug metformin.
Some patients with type 2 diabetes already take metformin and the newer drug, called Januvia, separately. Merck hopes the combination version will make it easier for those diabetics to control their blood sugar levels.
The Food and Drug Administration approved Januvia in October. That drug enhances the body's own ability to lower blood sugar levels. Novartis AG continues to seek FDA approval for a competing but similar drug, called Galvus.
|
|
|
Post by Paws on Jun 13, 2009 1:10:52 GMT 12.75
Januvia and Byeta, a similar drug via injection, are both under scrutiny and class action suit attributed to instances of pancreatitis and liver malfuntion. I've been on both regimens and will keep you posted on what follows.
|
|